Samsung Medison is garnering attention from the global medical community with its ultrasound diagnostic solutions across the women’s life stage from fetal stage to menopause.

At the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2025) in Cancún, Mexico on September 14, Samsung Medison will showcase its comprehensive women’s health solution under the theme “From Challenges to Solutions: Experience the Innovation.”

From Fetal Stage to Menopause Ultrasound Solution Demonstration Tailored to Women’s Life Stages

The highlight of upgraded HERA Z20, to be unveiled at ISUOG, features diagnostics tailored to every life stage of women. It supports healthcare professionals in managing women’s health comprehensively with a single equipment, enabling dedicated management of women’s health across all stages, from adolescent gynecological conditions and fertility to maternity and aging.

Newly added PelvicAssist and three types of reporting features propose diagnostic support innovation for the women and healthcare professionals whom have difficulties due to the gynecological conditions. PelvicAssist automatically analyzes multiple pelvic regions and measures the levator hiatus area, providing the 3D image.

Due to the complexity of anatomical structures, considerable time is required to precisely assess and report lesion location, size, shape and degree of invasion. In response, Samsung Medison has unveiled tailored diagnostic reporting solution based on standardized clinical guidelines.

Fibroid 2D, which simplifies the reporting procedure for uterine fibroid by applying The International Federation of Gynecology and Obstetrics (FIGO) guideline. IDEA and IETA highly enhanced diagnostic workflow efficiency by supporting scan procedures and reporting based on guidelines for endometriosis and endometrial tumor evaluation, respectively.

The ultra-compact probe Mini ER7, developed to minimize patient discomfort during gynecological examinations by offering 63% smaller head compared to conventional probes, it is expected to significantly reduce the burden for adolescent and elderly patients.

Ultrasound Solutions for High-risk Pregnancy Care and Enhanced Clinical Efficiency

With maternal age on the rise, high-risk pregnancies are becoming common. In response to this social challenge, Samsung Medison has integrated Ophthalmic Artery feature to detect systemic vasoconstriction in early stages — a key factor of pre-eclampsia.

As the Ophthalmic Artery branches directly from the internal carotid artery, it allows for indirect monitoring of cerebral blood flow, which is difficult to access, enabling the early detection of potential cardiovascular disease. The expanded HeartAssist further supports maternal health by real-time monitoring of cardiovascular conditions during pregnancy.

Healthcare professional’s work efficiency is at the center of Samsung Medison’s innovation. Live ViewAssist automatically extracts up to 39 ultrasound cross-sectional images, provides automated annotations and measurement results for key parameters throughout the pregnancy cycle, and reduce diagnostic time.

The integrated QualityCheck feature automatically evaluates the quality of extracted images during fetal diagnosis, supporting consistency of diagnostic accuracy.

Jihyun Kim, Head of the CX group at Samsung Medison said: “The Upgraded HERA 20 is more than just an equipment enhancement but it’s a total solution designed to support women’s health across all life stages. By combining AI technology with the healthcare professional’s clinical experience, we aim to enhance diagnostic accuracy and reduce burdens, ultimately driving meaningful change in the healthcare field.”

Samsung Electronics Health and Medical Equipment Business and Samsung Medison participated in the 2024 Radiological Society of North America (RSNA) conference in Chicago, United States, from December 1st to 5th (local time) and unveiling an even more diverse product lineup.

To strengthen its competitiveness across medical specialties, after the launch of a new OB & GYN ultrasound diagnostic system, HERA Z20, Samsung proposed ‘pediatric integrated solution’ encompassing the entire range of its medical diagnostic devices through this RSNA.

In the ‘Ultrasound Zone,’ a dedicated probe for the pediatric cardiac diagnosis ‘TA2-9’ was unveiled for the first time at this exhibition. The TA2-9 with 42% smaller head than adult echocardiography probe aids in more accurate diagnosis for congenital heart disease or functional and structural abnormalities of heart through the oral route. Also on display was ‘L3-22’, a dedicated neonatal probe featuring a smaller head compared to an adult version offering a wide frequency range which enables pediatric body scan with a single device without the need to switch probes.

All US Food and Drug Administration (FDA) 510(k) cleared products of Samsung digital X-ray have ‘low dose’ capability making it more appropriate for diagnosis of children and adolescents where safety is particularly prioritized. Samsung’s proprietary S-Vue imaging engine reduces radiation exposure by up to 50% compared to systems without this technology.

At this exhibition, Samsung launched a new ‘floor-mounted’ digital X-ray, GF 85. The new digital X-ray, GF 85 launched by Samsung is relatively affordable compared to ceiling-mounted type and cost-effective with the ability to be installed in a small space without ceiling construction. Moreover, it provides clear image quality even with low dose and is equipped with advanced AI diagnostic assistance feature, fully inheriting all the advantages of previous digital X-ray models.

NeuroLogica Corp, a subsidiary of Samsung Electronics, includes the OmniTom Elite mobile computed tomography (CT) in its portfolio, useful for imaging pediatric patients and at point-of-care, facilitating rapid clinical decision making and reducing transport related risks. Mobile CT is already recognized for its utility, with 8 out of the top 10 U.S. pediatric hospitals (as ranked by U.S. News for 2024-2025) utilizing the technology.

NeuroLogica’s OmniTom Elite with photon counting detector (PCD) technology showcased this year’s at RSNA delivers ultra high-resolution CT imaging at the point-of-care using FDA 510(k) cleared PCD technology, surpassing conventional CT methods that rely on energy integrating detectors. By utilizing photon counting detectors to measure the energy of each individual photon, this cutting-edge technology enhances contrast differentiation and virtual monoenergetic imaging, empowering radiologists with greater confidence in diagnosing patients.

Samsung provides opportunity to gain clinical application tips of Samsung medical devices and engage in Q&A with the global experts through Lunch & Learn session. In this session, a global breast imaging expert, Dr. Nina Vincoff shared a screening program using Samsung breast ultrasound solution and the latest insights on the FDA’s mandate for breast density information provision and implementation of additional imaging examination recommendation for dense breast (effective on September 10, 2024).

Dr. Farhad Farzanegan in Kasier Permanente South Sacramento health system U.S. presented a case study on hospital workflow improvement based on the result of CT intervention procedure using Samsung mobile full-body CT, BodyTom.

In the booth, Dr. Jon Jacobson, a musculoskeletal radiology expert, conducted live scan using a premium ultrasound diagnostic device, RS85 Prestige introducing clearer image quality and more sophisticated AI diagnostic assistance feature.

The leader of the Samsung Medison AI&Informatics group, Vijay, said “I discovered a greater potential through high praises from medical professors around the world who visited the site” and “Moving forward, we aim to further enhance our AI diagnostic support features tailored to specialized medical fields, solidify our technological leadership in radiology and obstetrics, and expand our competitiveness across all medical disciplines to pioneer new markets.”

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, participates the 34^th annual academic conference of ISUOG World Congress 2024 (International Society of Ultrasound in Obstetrics & Gynecology) held in Budapest, Hungary from 15 to 18 September.

Samsung Medison showcases HERA Z20, a new premium ultrasound system for OB&GYN, in ISUOG regarded as the most important academic conference in the world in the field of OB&GYN ultrasound.

HERA Z20 further enhanced the cutting edge AI diagnostic assistance features to improve health of women and fetuses. The Live ViewAssist provides a real-time diagnosis location, is newly integrated to HERA Z20. The Live ViewAssist reduces time required for measurement and increases accuracy by automatically classifying cross sections and providing measurement results for entire quarter of OB&GYN.

Live Q-scan and A-Focus features have been newly added to HERA Z20 to provide a more uniform image and sharper image quality. The Live Q-scan reduces noises that appear during the ultrasound examination in real-time, and A-Focus provides clearer images in every scanning depth. Crystal Architecture, Samsung Healthcare proprietary ultrasound imaging technology, also uses the upgraded second generation engine to increase clarity of image.

HERA Z20 enhances user convenience through My HERA going beyond the AI diagnostic assist feature. My HERA as a feature enabling user to build personalized ultrasound system by setting the diagnostic setting values for each user type in advance, can be customized depending on user preference.

Additionally, the EzStructure and EzFlow features provide convenient, optimal imaging settings for the anatomy to be examined with a single touch of a button. The main monitor and touch panel have freely adjustable angles and are ergonomically tailored for user convenience.

Samsung Medison plans to conduct a live scan of the HERA Z20 onsite to showcase the real-time AI diagnostic assist and reporting features that are faster and stronger than before.

In ISUOG, Samsung Medison also introduces theSUITE website for the first time along with HERA Z20 where educational contents of Samsung ultrasound system are complied. The new website membership registration event will be held to celebrate theSUITE launch in ISUOG. Samsung Medison will utilize theSUITE to improve access to the information of each product feature for domestic and overseas medical professionals and secure global bidding competitiveness.

Meanwhile, Samsung Medison pursues the realization of eco-friendly values based on IT technology of Samsung from the product development stage by minimizing energy consumption through analysis of customer’s product usage pattern.

HERA Z20 has reduced the product volume minimizing the number of components by incorporating circuit integration technology mainly utilized for mobile devices, etc. In addition, the packaging and cushioning materials are the replaced with 100% recycled paper by optimizing the packing design to withstand heavy load on paper, and eco-friendly recycled plastic material is utilized for the system body.

Samsung Medison designated part of exhibition hall as ‘eco-friendly zone’ and shares own energy policy at the booth that built using environmental friendly materials.

Kyutae Yoo, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison said “We are committed to doing our best to further increase global market share through launch of a new premium ultrasound system for OB&GYN, new educational website and synergy with Sonio which is equipped with exceptional AI reporting software,” and “We will leap forward as a global leader in the medical equipment industry by improving product performance and sustainability through technology innovation.”